1. Scrip
  2. >>Focus On Asia

Asia On The Move: New CFDA Directors, AZ China GM

 
• By Brian Yang

The China FDA has appointed several key directors and UK drug maker AstraZeneca has quietly changed its China head to a locally grown executive. Personnel changes also take place in major domestic maker Hisun, the China State Administration for Industry and Commerce (SAIC), Acucela and AdvaMed.

Asia On The Move is a regular column highlighting industry personnel changes in Asia-Pacific. The previous issue covered China’s new deputy TCM Commissioner ([A#28141201004]). Send

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from China

More from Focus On Asia